- Home
- ARBK vs GCTK Comparison
ARBK vs GCTK Comparison
Compare ARBK & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARBK | GCTK |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United Kingdom | United States |
| Employees | 25 | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.9K | 1.1M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | ARBK | GCTK |
|---|---|---|
| Price | $2.78 | $0.85 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.4K | ★ 1.5M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 31.22 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | $183.90 | N/A |
| Revenue Next Year | $26.78 | N/A |
| P/E Ratio | ★ N/A | $0.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.12 | $0.09 |
| 52 Week High | $28.64 | $15.90 |
Technical Indicators
Market Signals| Indicator | ARBK | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 31.09 |
| Support Level | $2.63 | N/A |
| Resistance Level | $3.15 | $5.96 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 29.53 | 22.93 |
Price Performance
Historical ComparisonAbout ARBK Argo Blockchain plc
Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.